RELAXO FOOTWEARS LTD.-$ - 530517 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on March 31, 2022 RELAXO FOOTWEARS LTD.-$ - 530517 - Compliance Certificate For The Year Ended On March 31, 2022 In Accordance With Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance Certificate for the Year ended on March 31, 2022 in accordance with Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 RELAXO FOOTWEARS LTD.-$ - 530517 - Closure of Trading Window
In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Policy for prevention of insider trading of the Company, 'Trading Window' for dealing in securities of the Company is closed from Friday, 1st April, 2022 till the end of 48 hours after the Financial Results of the Company for the quarter/ year ending 31st March, 2022 are made public. The date of the Board Meeting for the aforesaid purpose shall be intimated to you in due course. RELAXO FOOTWEARS LTD.-$ - 530517 - Change In The Name Of Our RTA From 'KFIN Technologies Private Limited' To 'KFIN Technologies Limited'.
Change in the name of our RTA from 'KFIN Technologies Private Limited' to 'KFIN Technologies Limited'. RELAXO FOOTWEARS LTD.-$ - 530517 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Funds Management Ltd
Hold Relaxo Footwears: target of Rs 1330: ICICI Direct
ICICI Direct recommended hold rating on Relaxo Footwears with a target price of Rs 1330 in its research report dated January 31, 2022.
RELAXO FOOTWEARS LTD.-$ - 530517 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for Un-Audited Financial Results for the quarter and nine months ended on December 31, 2021 Q3FY22 Quarterly Result Announced for Relaxo Footwears Ltd.
Footwear Relaxo Footwears declares Q3FY22 result: Q3 FY22 Revenue stood at Rs. 744 crore grew by 11% YoY Q3 FY22 EBITDA stood at Rs. 122 crore; Margins at 16.4% Q3 FY22 Profit After Tax stood at Rs. 70 crore; Margins at 9.4% Revenue grew by 11% at Rs. 744 crore as compared to Rs. 672 crore in the corresponding period of the previous year due to calibrated price hikes taken to mitigate impact of high raw material prices. EBITDA at Rs. 122 crore as compared to Rs. 149 crore in the corresponding period of the previous year. EBITDA Margins decreased by 577 bps YoY to 16.4% due to increase in raw material prices and additional margin offered to neutralize the impact of GST rate increase from 5% to 12% w.e.f. 1 st January, 2022 . Profit after Tax at Rs. 70 crore as compared to Rs. 90 crore in the corresponding period of the previous year. During the quarter additional capacity of 1.5 Lacs pair per day of footwear was commissioned at unit located in Bhiwadi Rajasthan, taking the total capacity across all categories and Plants to 10 Lacs pair per day of footwear. Revenue grew by 21% at Rs. 1,955 crore as compared to Rs. 1,611 crore in the corresponding period of the previous year. EBITDA down at Rs. 305 crore as compared to Rs. 333 crore in the corresponding period of the previous year. Profit after Tax down at Rs. 170 crore as compared to Rs. 189 crore in the corresponding period of the previous year. Commenting on the results and performance, Mr. Ramesh Kumar Dua, Managing Director said: “Indian economy continued to recover remarkably well from the pandemic induced disruptions and its quite commendable that India’s COVID vaccination coverage has crossed 150 crore mark, with almost 90% of the eligible population receiving at least one dose. Further, the government has started vaccination drive for youngsters in the age group 15-18 years. These developments seem to have helped curtail the mortality impact of the more transmissible Omicron variant and gives us hope that we will be able to come out of this quicker and stronger. We have taken calibrated price hike against unprecedented inflationary trend in raw material prices and current trend of raw material prices are easing out from its peak, which will give advantage in next year. The impact of GST rates will settle by the end of Q4, however, it will start giving advantage in unblocking of funds in inverted duty. During the quarter, we commissioned additional capacity of 1.5 lac pairs per day to cater to the growing demand and capture higher market share. We continue to remain consumer centric with best quality products, diverse portfolio, product innovation, strong market reach and continue to adopt strategic initiatives to capture expanding market opportunities in unexplored geographies to drive growth across all segments of our business. The company continued to enjoy comfortable liquidity position with zero net debt.” Result PDF RELAXO FOOTWEARS LTD.-$ - 530517 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Unaudited Financial Results for the quarter and nine months ended on 31st December, 2021.